Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Recruiting · NCT07728695 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Pelvic Infection, Urogenital Diseases, adenomyosis, endometriosis, female reproductive system disorder, pelvic inflammatory disease, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-27 | NCT07728695 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | 135 |
| Staci Gruber, Ph.D. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McLean Hospital | Belmont | United States | 47 |